Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In Vivo

Nuclear factor erythroid-2 related factor-2 (Nrf2) is an oxidative stress-response transcriptional activator that promotes carcinogenesis through metabolic reprogramming, tumor promoting inflammation, and therapeutic resistance. However, the extension of Nrf2 expression and its involvement in regula...

Descripción completa

Detalles Bibliográficos
Autores principales: Bovilla, Venugopal R., Kuruburu, Mahadevaswamy G., Bettada, Vidya G., Krishnamurthy, Jayashree, Sukocheva, Olga A., Thimmulappa, Rajesh K., Shivananju, Nanjunda Swamy, Balakrishna, Janardhan P., Madhunapantula, SubbaRao V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471069/
https://www.ncbi.nlm.nih.gov/pubmed/34572304
http://dx.doi.org/10.3390/biomedicines9091119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471069/
https://www.ncbi.nlm.nih.gov/pubmed/34572304
http://dx.doi.org/10.3390/biomedicines9091119

Ejemplares similares